Industry News

Soliris Becomes The First ‘Ultra-Orphan’ Drug Backed By NICE

Do You Think Express Scripts Made The Wrong Decision With Viekira Pak?

Watch Out High Cholesterol – Here Come The Super Statins

What Exactly Is The Health Care Transformation Task Force?

Listen To This Podcast On Quality Measures With CMS’ Goodrich

Americans Hit With Double Digit Increases In Prescription Drug Prices In 2014

Medical Affairs Reputations In Oncology (US): Oncologists Rate Key Products And Companies

Medical Affairs Reputations In Oncology (EU5): Oncologist Rate Key Products And Companies

FirstWord’s – Reshaping Medical Affairs: Delivering Value To KOLs And Payers

Optimal KOL Relationship Management – Are Digital Channels The Whole Answer?

How Much Does Real World Evidence Really Matter In Health Technology Assessments?

Are Mobile Apps Helping HIV Patients Achieve Viral Suppression?

Get With The PRO-gram – Exploring The Future Of Patient-Reported Outcomes

Gilead To Allow Generic Drug Makers To Produce New – More Effective Hep C Treatment

HealthEconomics.Com Ready To Scale It Up!

A Look At The Life Of ACOs

Elizabeth Warren – Ready To Hold Big Pharma Accountable

New Hep C Drug Deal Keeps All Players On The Field

Pfizer Managed Care Pharmacy Summer Internship Program Deadline – Friday January 30

Four Major Reasons Backing The ‘Pharmatization’ Of Specialty Drugs

Should Medicaid’s “Fee Bump” Stay For 2015?

Alexion Faces Allegations Of Excessive Pricing In Canada

Is The U.S. Healthcare Website Putting Your Privacy At Risk?

Don’t Miss ISPOR’s 5th Latin America Conference

Express Scripts & Cancer Drug Prices – Looking Ahead To 2016!

G-BA Finds Considerable Additional Benefit In Advanced Breast Cancer Drug

What Is The Real Reason Behind Sovaldi’s Delay In England?

A Giant Drug Company That Doesn’t Invent Medicines?

Continuum Clinical Expands Global Presence By Adding Medical Communications Executive

What Impact Have Price-Cap Regulations Had On Generic Pharmaceutical Firms In Canada?


Stay Connected